Evidence map›Paper›PMID 34199434›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Optimal Halbach Configuration for Flow-through Immunomagnetic CTC Enrichment.

Michiel Stevens, Peng Liu, Tom Niessink, Anouk Mentink, Leon Abelmann, Leon Terstappen

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Clinical application of circulating tumor cells.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michiel StevensDepartment of Medical Cell BioPhysics, University of Twente, 7522 NB Enschede, The Netherlands.ORCID 0000-0001-8643-7235
Peng LiuDepartment of Medical Cell BioPhysics, University of Twente, 7522 NB Enschede, The Netherlands.ORCID 0000-0002-9500-7357
Tom NiessinkDepartment of Medical Cell BioPhysics, University of Twente, 7522 NB Enschede, The Netherlands.
Anouk MentinkDepartment of Medical Cell BioPhysics, University of Twente, 7522 NB Enschede, The Netherlands.
Leon AbelmannKIST Europe Forschungsgesellschaft mbH, 66123 Saarbrücken, Germany.ORCID 0000-0002-9733-1230
Leon TerstappenDepartment of Medical Cell BioPhysics, University of Twente, 7522 NB Enschede, The Netherlands.ORCID 0000-0001-5944-3787

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the low frequency of circulating tumor cells (CTC), the standard CellSearch method of enumeration and isolation using a single tube of blood is insufficient to measure treatment effects consistently, or to steer personalized therapy. Using diagnostic leukapheresis this sample size can be increased; however, this also calls for a suitable new method to process larger sample inputs. In order to achieve this, we have optimized the immunomagnetic enrichment process using a flow-through magnetophoretic system. An overview of the major forces involved in magnetophoretic separation is provided and the model used for optimizing the magnetic configuration in flow through immunomagnetic enrichment is presented. The optimal Halbach array element size was calculated and both optimal and non-optimal arrays were built and tested using anti-EpCAM ferrofluid in combination with cell lines of varying EpCAM antigen expression. Experimentally measured distributions of the magnetic moment of the cell lines used for comparison were combined with predicted recoveries and fit to the experimental data. Resulting predictions agree with measured data within measurement uncertainty. The presented method can be used not only to optimize magnetophoretic separation using a variety of flow configurations but could also be adapted to optimize other (static) magnetic separation techniques.

Indexed as

circulating tumor cellenrichmentfinite element modelflowHalbachmagnetic

Identifiers

PMID34199434
PMCPMC8229094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.